Noreen Henig
Director/Board Member presso AVIDITY BIOSCIENCES, INC.
Patrimonio netto: 8 118 $ in data 31/03/2024
Profilo
Noreen Roth Henig is an Independent Director at Avidity Biosciences, Inc. and Lazard Growth Acquisition Corp.
I, and an Independent Director at Lazard Healthcare Acquisition Corp.
I.
She previously worked as Senior Director-Global Respiratory at Gilead Sciences, Inc., Director-Adult Cystic Fibrosis Care Centers at Cystic Fibrosis Foundation, Chief Development Officer at ProQR Therapeutics NV, Chief Medical Officer at Kezar Life Sciences, Inc., and Chief Medical Officer at Breath Therapeutics GmbH.
She received her undergraduate degree from Yale University in 1987 and her doctorate from Albert Einstein College of Medicine, Inc. in 1991.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
KEZAR LIFE SCIENCES INC
0.01% | 24/07/2023 | 9 000 ( 0.01% ) | 8 118 $ | 31/03/2024 |
AVIDITY BIOSCIENCES INC
-.--% | 15/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Noreen Henig
| Società | Posizione | Inizio |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Director/Board Member | 22/08/2019 |
| LAZARD GROWTH ACQUISITION CORP. I | Director/Board Member | 09/02/2021 |
Lazard Healthcare Acquisition Corp. I
 Lazard Healthcare Acquisition Corp. I Financial ConglomeratesFinance Lazard Healthcare Acquisition Corp. I is a blank check company, which engages in mergers, share exchanges, asset acquisitions, share purchases, and reorganizations. The company was founded on February 25, 2021 and is headquartered in New York, NY. | Director/Board Member | - |
Precedenti posizioni note di Noreen Henig
| Società | Posizione | Fine |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 06/10/2023 |
Breath Therapeutics GmbH
 Breath Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breath Therapeutics GmbH is a clinical stage biopharmaceutical company, which engages in the development of inhaled therapeutics for respiratory diseases. It offers drug device platform, which consists of liposomal drug-aerosol formulations and cutting-edge inhalation technology. The company was founded by Jens Stegemann, Gerhard Boerner, Oliver Denk, and Anne Burger in 2016 and is headquartered in Munchen, Germany. | Chief Tech/Sci/R&D Officer | 01/03/2020 |
| PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 01/12/2017 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/2014 |
Cystic Fibrosis Foundation
 Cystic Fibrosis Foundation Medical/Nursing ServicesHealth Services Cystic Fibrosis Foundation is a donor-supported non-profit organization which focuses in the search for a cure for cystic fibrosis. The foundation funds cystic fibrosis research. It also supports and accredits a national care center network recognized by the National Institutes f Health as a model of care for a chronic disease. The company was founded in 1955 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01/01/2008 |
Formazione di Noreen Henig
| Yale University | Undergraduate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| AVIDITY BIOSCIENCES, INC. | Health Technology |
| PROQR THERAPEUTICS N.V. | Health Technology |
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation Medical/Nursing ServicesHealth Services Cystic Fibrosis Foundation is a donor-supported non-profit organization which focuses in the search for a cure for cystic fibrosis. The foundation funds cystic fibrosis research. It also supports and accredits a national care center network recognized by the National Institutes f Health as a model of care for a chronic disease. The company was founded in 1955 and is headquartered in Bethesda, MD. | Health Services |
Breath Therapeutics GmbH
Breath Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breath Therapeutics GmbH is a clinical stage biopharmaceutical company, which engages in the development of inhaled therapeutics for respiratory diseases. It offers drug device platform, which consists of liposomal drug-aerosol formulations and cutting-edge inhalation technology. The company was founded by Jens Stegemann, Gerhard Boerner, Oliver Denk, and Anne Burger in 2016 and is headquartered in Munchen, Germany. | Health Technology |
Lazard Growth Acquisition Corp. I
 Lazard Growth Acquisition Corp. I SemiconductorsElectronic Technology Lazard Growth Acquisition Corp. I operates as a blank check company with the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase and reorganization or similar business combination with one or more businesses. The company was founded on December 10, 2020 and is headquartered in New York, NY. | Electronic Technology |
Lazard Healthcare Acquisition Corp. I
Lazard Healthcare Acquisition Corp. I Financial ConglomeratesFinance Lazard Healthcare Acquisition Corp. I is a blank check company, which engages in mergers, share exchanges, asset acquisitions, share purchases, and reorganizations. The company was founded on February 25, 2021 and is headquartered in New York, NY. | Finance |
- Borsa valori
- Insiders
- Noreen Henig
